Comparison of bioactive material failure rates in vital pulp treatment of permanent matured teeth – a systematic review and network meta-analysis

Mineral Trioxide Aggregate (MTA) is the gold standard for vital pulp treatment (VPT), but its superiority over novel calcium silicate-based cements in permanent teeth lacks systematic evidence. This study aimed to compare the efficacy of these materials in VPT through a network meta-analysis. A systematic search was conducted in MEDLINE, EMBASE, Cochrane Library, and Web of Science until January 20, 2024. The inclusion criteria were randomized controlled trials involving VPT with biomaterials and reversible or irreversible pulpitis diagnoses in mature permanent teeth. The primary outcome was the odds ratio (OR) of failure rates with 95% confidence intervals. In the 21 eligible trials, failure rates were significantly higher with calcium-hydroxide than MTA at six (OR 2.26 [1.52-3.36]), 12 (OR 2.53 [1.76-3.62]), and 24 months (OR 2.46 [1.60-3.79]). Failure rates for Totalfill at six (OR 1.19 [0.55-2.58]) and 12 months (OR 1.43 [0.71-2.92]), and Biodentine at six (OR 1.09 [0.66-1.78]), 12 (OR 1.21 [0.74-1.96]), and 24 months (OR 1.47 [0.81-2.68]) were not significantly different from MTA. The results were similar in the direct pulp capping subgroup, whereas, in the partial and full pulpotomy subgroup, there was not enough evidence to achieve significant differences. MTA, Biodentine, and Totalfill are the most efficient materials for VPT. However, calcium-hydroxide-based materials are not recommended in VPT.


Inclusion criteria for studies
Randomized controlled trials were included.Studies with preoperative diagnosis, a description of the clinical procedure, and biomaterials.Studies with the initial diagnosis of reversible or irreversible pulpitis or Wolters classification-based pulpitis 47 .The failure of VPT was defined as having clinical symptoms, pain, sensitivity to cold and percussion tests, and/or signs of periapical inflammation.The number of study participants in each follow-up period is defined.The minimum follow-up period was six months.

Exclusion criteria for studies
The exclusion criteria of studies are the following: case reports, two-armed interventional, cohort, and casecontrolled studies, meta-analyses, reviews, animal studies, conference abstracts, non-English written papers, and the study population involved primary dentition, immature permanent teeth, and trauma cases.

Information sources and search strategy
An electronic literature search was conducted using the following databases: MEDLINE (PubMed), EMBASE, Cochrane Library, and Web of Science.A citation chase was performed (https:// www.rayyan.ai/).The following search key was used: (vital pulp therapy OR vital-pulp therapy OR direct pulp capping OR direct pulp-capping OR indirect pulp capping OR indirect pulp-capping OR partial pulpotomy OR partial-pulpotomy OR full pulpotomy OR full-pulpotomy OR pulp capping OR pulp-capping) AND (Biodentine OR CEM OR Calcium Silicate Sealer OR Calcium-silicate based materials OR calcium silicate-based material OR calcium hydroxide OR MTA OR pulp capping material* OR calcium silicate OR calcium silicate materials OR biomaterial*) AND (Adult* OR mature tooth OR mature teeth OR permanent teeth OR permanent tooth OR permanent OR mature).

Selection process
The entire selection process was conducted simultaneously by two independent observers (P.K. and O.V.), with each observer evaluating articles based on their title, abstract, and full text.The first screening involved the titles and the abstracts of the articles.Then, a full-text selection was completed for all studies that met the inclusion criteria or when there was insufficient information in the abstract to make a proper decision.Conflicts were resolved through discussion with the two reviewers.The same two independent researchers reviewed the full texts for quality and inclusion in the network meta-analysis.A third author (K.K.) was also involved in case of disagreement.

Data collection/extraction process
Two independent observers collected data, P.K. and O.V. No automatic tools were used for data extraction.First, the data of some articles that matched the inclusion criteria was extracted into an MS Excel sheet form.The statistician verified the form first.Studies declared that only the percentage of failed and successful cases without absolute numbers were excluded from the meta-analysis.

Data items/Effect measure
The verified MS Excel form was used for data extraction of all included studies, comprising the following information: publication information (author/year), study type, demographics of study participants, pulpal diagnosis, type of vital pulp treatment, materials applied, follow-up times, and numbers lost to follow-up.The primary outcomes were vital pulp treatment failure rates after six months, 12 months, and 24 months.The effect measure was the odds ratio (OR) with 95% confidence intervals 48 .If the tested material had an odds ratio of higher than one, indicating a higher failure rate for the tested material than for the MTA group.Some studies [49][50][51][52][53] did not calculate the previously lost unsuccessful cases for every follow-up.Therefore, the authors of this study added the number of unsuccessful lost cases to the number of participants at the subsequent follow-up for the meta-analysis to obtain the actual failure rate.

Risk of bias (RoB) assessment
According to the Cochrane Collaboration, the risk of bias in the randomized clinical trials was analyzed by the Risk of Bias 2 tool (https:// metho ds.cochr ane.org/ bias/ resou rces/ rob-2-revis ed-cochr ane-risk-bias-tool-rando mized-trials).The Risk of Bias 2 tool consists of five domains: randomization process (D1), deviations from intended interventions (D2), missing outcome data (D3), measurement of outcome (D4), selection of reported results (D5).Each domain can have three different results: low risk, some concern, and high risk.The worst domain result will set the overall bias of the particular study.

Synthesis methods
First, pooled analysis was performed separately for data from all treatment modalities (including indirect and direct pulp capping and partial and full pulpotomy) at each follow-up interval (6, 12, and 24 months).In the second step, subgroup analysis was conducted separately for each treatment modality (indirect pulp capping, direct pulp capping, partial pulpotomy, and full pulpotomy) at each follow-up interval, provided a minimum of three eligible studies were available for each subgroup.
A frequentist method was used to perform the network meta-analyses (NMAs).As we assumed considerable between-study heterogeneity due to the nature of medical treatments and conditions, a random-effects model was used to pool effect sizes (ORs) with a 95% confidence interval (95% CI).The reason for using this method for dichotomous data is zero events in the studies.This method handles zero events with correction.The network plot indicates the strength of the comparisons between materials by depicting the number of patients and studies.
The three follow-up periods were analyzed in a stratified manner.Forest plots were used to examine the consistency of the relationship between direct, indirect, and network point estimates.Consistency means that the relative effect of a comparison based on direct evidence does not differ from the one based on indirect evidence 54 .The evidence plot shows direct and indirect estimation ratios in the network meta-analysis.Funnel plots were constructed for all outcomes, and Egger's tests were performed to assess the small-study effect.P-scores rank treatments, which measure the certainty that one treatment is better than another treatment, and are averaged over all competing treatments.P-score ranges from 0 to 1, with higher values indicating higher ranks.Calculations were performed using the R package (version 4.1.1),Netmeta (version 2.7-0), and Pairwise (version 0.6.0-0).Netmeta could estimate network meta-analysis models within a frequentist framework and derive from graph-theoretical techniques initially developed for electrical networks 55 .

Certainty assessment
The certainty assessment was evaluated according to CINeMA (Confidence in Network Meta-Analysis).CINeMA includes six domains: within-study bias, reporting bias, indirectness, imprecision, heterogeneity, and incoherence 56,57 .There are three levels of judgment for each domain (no concerns, some concerns, or major concerns).Domain judgments can be summarized into four confidence levels for each outcome: very low, low, moderate, or high.

Study characteristics
Baseline characteristics of the 21 included studies are presented in (Table 1).The number of treated and lost patients and the successful and unsuccessful cases in every follow-up period, funding source, and conflict of interest were recorded.The network plot (Figs.2A, 3A, 4A, 5A, 6A, 7A,8A, 9A, 10A, 11A) indicates the number of direct comparisons between materials for the 6, 12, and 24 month follow-up periods.The description of the used materials is presented in Supplementary Table 2.

Risk of Bias assessment
Five studies showed high risk, twelve had some concern, and four indicated low risk (Supplementary Fig. 1).

Assessment of publication bias
All funnel plots were inverted and symmetric in all follow-up periods and subgroups, indicating no small study effect (Supplementary Figs.2-11).Egger's p values also indicate the lack of publication bias in all three follow-ups 72,73 .

Certainty of evidence
After comparing materials based on pooled data at each follow-up interval, concerns regarding imprecision and heterogeneity prompted a downgrade in the certainty of evidence.The heterogeneity in pooled data at six and 24 month data was more pronounced.It was pronounced at those material comparisons where the number of direct data was small.Similarly, imprecision, heterogeneity, and incoherence warranted downgrading within the direct pulp capping subgroups.The appearance of heterogeneity in the direct pulp capping subgroup at all follow-up periods was pronounced.It was also pronounced in those material comparisons where the number of direct data was few.The main concerns in imprecision and heterogeneity were observed in the indirect pulp capping subgroup.The main concern in the partial and full pulpotomy subgroups was imprecision (see www.nature.com/scientificreports/Supplementary Figs.12-37).Consequently, the certainty of evidence ranged from high to very low across all subgroups.

Pooled data, including all treatment modalities at the six-month follow-up
The total number of patients included in the network analysis was 1932, with 257 failure events.The comparison structure is depicted in the network graph (Fig. 2A).Based on the p-score (Fig. 2B), the materials ranked from lowest to the highest OR as follows: CEM, MTA, Biodentine, TotalFill, TheraCalLC, Ca(OH) 2 , Ca(OH) 2 LC.No significant difference was observed in the OR between CEM, Biodentine, Totalfill, and TheraCalLC groups compared to MTA (Fig. 2C, Supplementary Figs.38, 48).However, the OR was significantly higher in the Ca(OH) 2 and Ca(OH) 2 LC groups than in the MTA group.

Pooled data, including all treatment modalities at the 12 month follow-up
The total number of patients in the network analysis was 2158, with 333 failure events.The comparison structure is depicted in the network graph (Fig. 3A).Based on the p-score, the materials ranked from lowest to the highest OR as follows: MTA, CEM, Biodentine, TotalFill, TheraCalLC, Ca(OH) 2 , and Ca(OH) 2 LC (Fig. 3B).No significant difference was observed in the OR between CEM, Biodentine, and TotalFill groups compared to MTA (Fig. 3C, Supplementary Figs.39, 49).However, the OR was significantly higher in the TheraCalLC, Ca(OH) 2, and Ca(OH) 2 LC groups than in the MTA group.

Pooled data, including all treatment modalities at the 24 month follow-up
The total number of patients in the network analysis was 1107, with 257 failure events.The comparison structure is illustrated in the network graph (Fig. 4A).Based on the p-score, the materials ranked from lowest to the highest OR as follows: MTA, Biodentine, TheraCalLC, TotalFill, CEM, Ca(OH) 2 , and Ca(OH) 2 LC (Fig. 4B).The probability of MTA's rank gradually increased from six to 24 months.
No significant difference was observed in the OR between Biodentine, TotalFill, and CEM groups compared to MTA (Fig. 4C, Supplementary Figs.40, 50).However, there was no direct comparison between CEM and the other materials except between CEM and MTA.The OR was significantly higher in TheraCalLC, Ca(OH) 2 , and Ca(OH) 2 LC groups than in the MTA group.

Indirect pulp capping at the six-month follow-up
Four studies were included with 239 patients and 17 failure events.The comparison structure is illustrated in the network graph (Fig. 5A).Based on the p-score (Fig. 5B), the materials ranked from lowest to highest OR are Biodentine, MTA, Ca(OH) 2 .No significant difference was observed in the OR between Biodentine and Ca(OH) 2 groups compared to MTA (Fig. 5C, Supplementary Figs.41, 51).

Direct pulp capping at the six-month follow-up
Seven studies were included with 1243 patients and 182 failure events.The comparison structure is depicted in the network graph (Fig. 6A).Based on the p-score (Fig. 6B), the materials ranked from lowest to highest OR are as follows: CEM, MTA, Biodentine, TheraCalLC, Ca(OH) 2 , Ca(OH) 2 LC.No significant difference was observed in the OR between CEM, Biodentine, and TheraCalLC groups compared to MTA (Fig. 6C, Supplementary Figs.42, 52).Failure was significantly more likely in Ca(OH) 2 and Ca(OH) 2 LC groups higher than in the MTA group.However, there were just two direct comparisons of CEM with Ca(OH) 2 and MTA.

Direct pulp capping at the 12 month follow-up
Six studies were included, with 1122 and 231 failure events.The comparison structure is illustrated in the network graph (Fig. 7A).Based on the p-score, the materials ranked from lowest to the highest OR as follows: CEM, MTA, Biodentine, TheraCalLC, Ca(OH) 2 , and Ca(OH) 2 LC (Fig. 7B).No significant difference in the OR was observed between CEM, Biodentine, and TheraCalLC groups compared to MTA (Fig. 7C, Supplementary Figs.43, 53).The OR was significantly higher in TheraCalLC, Ca(OH) 2, and Ca(OH) 2 LC groups than in the MTA group.

Direct pulp capping at the 24 month follow-up
Three studies were included with 667 patients and 209 failure events.The comparison structure is shown in the network graph (Fig. 8A).Based on the p-score, the materials ranked from lowest to the highest OR as follows: MTA, Biodentine, TheraCalLC, Ca(OH) 2 , and Ca(OH) 2 LC (Fig. 8B).
No significant difference was observed in the OR between Biodentine compared to MTA (Fig. 8C, Supplementary Figs.44, 54).The OR was significantly higher in TheraCalLC, Ca(OH) 2, and Ca(OH) 2 LC groups than in the MTA group.

Partial pulpotomy at the 12 month follow-up
Three studies were included with 250 patients and 33 failure events.The comparison structure is shown in the network graph (Fig. 9A).Based on the p-score (Fig. 9B), the materials ranked from lowest to the highest OR are as follows: Biodentine, MTA, TotalFill, Ca(OH) 2 .

Full pulpotomy at the six-month follow-up
Three studies were included with 207 patients and 27 failure events.The comparison structure is shown in the network graph (Fig. 10A).Based on the p-score (Fig. 10B), the materials ranked from lowest to highest OR are as follows: Ca(OH) 2 , TotalFill, MTA, and Biodentine.No significant difference was observed in the OR between Ca(OH) 2 , TotalFill, and Biodentine groups compared to MTA (Fig. 10C, Supplementary Figs.46, 56).

Full pulpotomy at the 12 month follow-up
Four studies were included with 581 patients and 56 failure events.The comparison structure is depicted in the network graph (Fig. 11A).Based on the p-score (Fig. 11B), the materials ranked from lowest to highest are as follows: Biodentine, Ca(OH) 2 , MTA, TotalFill, and CEM.Compared to MTA, the OR was not significantly different between the Biodentine, Ca(OH)2, TotalFill, and CEM groups (Fig. 11C, Supplementary Figs.47, 57).In contrast to our results, most previous studies 34,49,62,64 found no significant difference between Ca(OH) 2 and MTA at six-month follow-ups.Despite the higher odds ratio for Ca(OH) 2 and for Ca(OH) 2 LC than for MTA, the limited sample size of the individual studies prevented a conclusion from being drawn.However, synthesizing the individual study results by meta-analysis could provide a high level of evidence 74,75 .
In addition, a recent retrospective cohort study 76 has found success rates of 100%, 95%, 95%, 86%, and 89% for direct pulp capping at 1, 5, 10, 20, and 35 years of follow-up with Ca(OH) 2 (Dycal, Dentsply), respectively.However, the careful methodology developed by the author might explain these excellent results.In the case of medium/large pulp exposure, the calcium-hydroxide powder was applied to the pulp to control the moisture before Dycal application.It is important to note that the same person performed the treatment and evaluation, indicating a possible bias.
Most randomized clinical trials that compared Ca(OH) 2 to MTA 49,50,[61][62][63][64]67,68,71 included teeth with reversible pulpitis and direct or indirect pulp capping without pulpotomy. The succss rates of these studies varied widely, between 58 and 96% at six months, 64 and 92% at 12 months, and 40 and 92% at 24 months.However, the success rates of MTA in the same studies (direct comparison) were more consistent, between 84 and 100% at six months and 83 and 98% at 12 months.At 24 months, the success rates ranged from 85 to 100% after excluding one study 61 .This study reported a crude failure rate of 13.6%.However, to align with the methodology of other studies in the meta-analysis, the failure rate was recalculated, excluding lost cases.This recalculation yielded an unrealistically low failure rate of 45% with MTA.The involvement of 43 dental practices may have introduced bias, leading to the loss of an exceptionally high number of cases (135 out of 183) during follow-up, thus significantly distorting the reported rates.
No subgroup analysis could be conducted in this meta-analysis for pulpotomy because only one randomized clinical trials 34 performed pulpotomy with Ca(OH) 2 .In that particular study, the odds ratios for Ca(OH) 2 /MTA were high: 3.23 at six months, 4.09 at 12 months, and 7.15 at 24 months, indicating a clear advantage of MTA over the Ca(OH) 2 in pulpotomy after irreversible pulpitis.
In a histological study on animals, Ca(OH) 2 induced less dentin bridge formation after direct pulpal application than MTA 77 .Twelve of the 15 teeth that underwent Ca(OH) 2 treatment developed pulp inflammation; only the rest formed dentin bridges without signs of inflammation.It is hypothesized that the inadequate adhesion of calcium-hydroxide-based materials to the tooth structure, their low mechanical strength, and solubility can result in microleakage and dental pulp infection 78 .Ca(OH) 2 forms only a weak mineralized barrier with high permeability.The high dissolvability of Ca(OH) 2 disintegrates the material, leaving voids 79 .This is a potential way for reinfection and a possible reason for the higher failure rate in VPT 79 .
Compact hard tissue formation without bacterial invasion is crucial for successful vital pulp treatment, and this depends on the sealing ability of the capping material 80 .In contrast to Ca(OH) 2 , bioactive tricalcium silicatebased cements can create an ideal healing environment and form reparative dentin 81 .They also have a better sealing ability than CaOH 2 , which is likely one of the main reasons for their success 79,80 .
The hypothesis that the newer bioactive materials would be as efficient in VPT as MTA was partially rejected as TheraCalLC was inferior to MTA at 12 and 24 months by significant odds ratios of 2.09 and 2.10.TheraCalLC is a resin-modified light-curing calcium silicate-based material.The TheraCalLC was only used for direct pulp capping in the included studies.The material has low solubility, fast setting time, and good sealing ability 82 .However, no calcium-hydroxide formation was observed during hydration with TheraCalLC 83 .Calciumhydroxide is highly effective in stimulating odontoblast activity, directly resulting in mineralization 84 .Therefore, these specific properties might be attributed to the low performance at 12 and 24 months.
CEM has an antimicrobial effect 37 and a good sealing ability 36 , which are essential for the success of VPT.This meta-analysis comparing CEM to MTA, including all treatment modalities, indicated a non-significant odds ratio of 0.15, 0.97, and 3.32 at six, 12, and 24 months.Similar results were obtained in the direct pulp capping subgroup with reversible pulpitis at both six and 12 month follow-ups in the full pulpotomy subgroup with irreversible pulpitis at 12 months.However, only three randomized clinical trials 4,60,67 could be included for comparison between CEM and MTA.Consequently, more studies are necessary to increase the level of evidence for CEM.
The network meta-analysis showed that Totalfill was not inferior to MTA at each follow-up in the pooled subgroups.Three studies were included in the six-and 12-month follow-ups, but only one study in the 24 month follow-ups.The TotalFill demonstrated non-inferiority to MTA in the 12 month partial pulpotomy and six-and 12 month full pulpotomy subgroups.It should be noted that the partial pulpotomy subgroup included one study with TotalFill, while the full pulpotomy subgroups included three studies.Totalfill is a calcium silicate-based repair material with beneficial biological properties 58 .The manufacturer already premixes TotalFill, so no further preparation is required.TotalFill demonstrates optimal biocompatibility, no cytotoxicity, and has an osteogenic property 85 .Totalfill does not shrink during setting and is hydrophilic and insoluble in tissue fluids 86 .
The current meta-analysis showed that the clinical efficacy of Biodentine in VPT is not inferior to MTA in any subgroups of treatment modality, suggesting that it has an excellent alternative.Biodentine shows high cytocompatibility 87 and has good antimicrobial potential 88 .Fast setting time and less discoloring potential are favorable clinical properties 30 .Biodentine has beneficial regenerative properties that improve dental pulp stem cell proliferation, attachment, and migration 89 .Furthermore, Biodentine was more effective in promoting mineralization than MTA 90 .
A recently published meta-analysis compared calcium silicate and hydroxide-based materials to MTA 91 .However, this study performed a network meta-analysis to compare all materials studied directly and indirectly.Through the network meta-analysis, additional materials could be included, such as TheraCalLC, TotalFill, and Ca(OH) 2 LC.Consequently, materials could be ranked according to their clinical efficacy.Another distinction was that we excluded immature and trauma cases and focused solely on mature permanent teeth, which is more clinically relevant for dentists treating adult patients.In addition, we included 24-month follow-up periods contrary to the 12 month follow-up in the previous study.Although the authors of the previous meta-analysis www.nature.com/scientificreports/noted that additional studies were required to determine success rates accurately, we addressed this issue using a bias elimination calculation method.

Strengths and limitations
An essential strength of the current analysis is that all studies included were randomized controlled trials with large sample sizes.In addition, some original data was reevaluated to derive precise estimates of odds ratios by standardizing the calculation across the studies.A successful subgroup analysis for the direct pulp capping revealed that Ca(OH) 2 performs poorly even in the least severe pulp lesions.However, the present study has limitations due to weak arms for some of the comparisons and subgroups.Specifically, CEM was compared only to MTA and Ca(OH) 2 at six and 12 months and only to MTA at 24 months, whereas Totalfill was only compared to MTA and Biodentine and Ca(OH) 2 .In addition, CEM was used in only three studies, warranting caution in interpreting the results.These weaker comparison arms may impact the accuracy of the findings.However, as the odds ratio of conventional Ca(OH) 2 is significantly higher than MTA, it would be unfeasible and ethically questionable to include Ca(OH) 2 in a large-scale study comparing new bioactive materials to it.
In the pooled results, heterogeneity was not a severe problem.However, in subgroup analyses, heterogeneity increased, but imprecision was the primary concern.This is because there are few randomized clinical trials with more clinically complicated situations, such as symptomatic cases with a partial or complete pulpotomy.Four studies 4,53,58,69 included full pulpotomy, and three studies 34,68,70 included partial pulpotomy.In one study 60 , the extent of the pulpotomy was not defined, and another study did not distinguish between direct pulp capping and full pulpotomy 51 .The rest of the studies did not apply pulpotomy or did not declare it.
The longest follow-up in the included studies was 24 months, except for one article, Peskersoy et al. 64 .The limited duration of follow-up for VPT restricts the ability to draw long-term conclusions from the results.

Implications for research
A review of the articles clarified that critical demographic data, such as sex, age, and tooth types, were either not published or lacked stratified results.Given the influence of age in clinical decision-making, it is necessary to conduct studies involving mature permanent teeth, including middle-aged and possibly elderly individuals.
It is also crucial to report the number of cases lost to follow-up and calculate failure rates considering the lost cases.
In conventional asymptomatic pulp capping, MTA has shown promising results.However, neither study directly compared the reversible and irreversible pulpitis; many did not classify the pulpal state, nor did the studies use the Wolters classification 47 .Further studies with larger sample sizes are needed to establish the best clinical practice for treating irreversible pulpitis, as recommended by Wolters et al. 47 .
More extended follow-up periods are strongly recommended.Some of the included studies did not report all follow-up periods.It would also be helpful to look at the trends in failure over the whole follow-up period.

Implications for practice
Ca(OH) 2 is not recommended for any vital pulp treatment, including pulp capping.However, newer calcium silicate-based materials such as Biodentine and Totalfill, which offer improved treatment properties, can be considered as alternatives to MTA.Based on the results of the present study, it can be concluded that MTA has the best clinical performance in VPT.It is important to emphasize that the handling and setting time of MTA is worse than that of Biodentine.In those clinical situations where setting time is relevant, Biodentine is the preferred material.Newer MTA products may be better at handling tooth discoloration, but they are still inferior to Biodentine.In cases where aesthetics are mandatory (in the anterior region), Biodentine could be a better alternative for VPT.Failure can occur even after six months without symptoms, so long-term monitoring is essential.

Conclusion
The network meta-analysis indicated a high to very low confidence rating that Mineral Trioxide Aggregate and Biodentine are superior materials for vital pulp treatment during 6, 12, and 24 months compared to calciumhydroxide-based materials.Based on the 2-3 times higher failure rate, the clinical application of Ca(OH) 2 and Ca(OH) 2 LC for VPT can no longer be recommended for direct pulp-capping for pulpotomy.With a moderate to low confidence rating, Biodentine and Totalfill could be a suitable MTA substitute.

Figure 1 .
Figure 1.Prisma 2020 flow diagram of the screening and selection process.

Figure 2 .
Figure 2. Comparing MTA and investigated bioactive materials at 6 months follow-up-pooled data, including all treatment modalities (A) Network-plot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 3 .
Figure 3. Comparing MTA and investigated bioactive materials at 12 months follow-up-pooled data, including all treatment modalities (A) Network-plot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 4 .
Figure 4. Comparing MTA and investigated bioactive materials at 24 months follow-up-pooled data, including all treatment modalities (A) Network-plot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 5 .
Figure 5. Comparing MTA and investigated bioactive materials at 6 months follow-up-indirect pulp capping (A) Network-plot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 6 .
Figure 6.MTA and investigated bioactive materials at 6 months follow-up-direct pulp capping (A) Networkplot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 7 .
Figure 7. MTA and investigated bioactive materials at 12 months follow-up-direct pulp capping (A) Networkplot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 8 .
Figure 8. MTA and investigated bioactive materials at 24 months follow-up-direct pulp capping (A) Networkplot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 9 .
Figure 9. Comparing MTA and investigated bioactive materials at 12 months follow-up-partial pulpotomy (A) Network-plot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Figure 10 .
Figure 10.Comparing MTA and investigated bioactive materials at 6 months follow-up-full pulpotomy (A) Network-plot: An orange circle represents every bioactive material; the circle size represents the number of treated patients.The width of the lines and the numbers represent the number of studies where a direct comparison was made.(B) P-score: The p-score represents a ranking between the compared materials.(C) Outcome forest plot: The zero effect is the MTA vs. the other materials.The grey squares represent the odds ratio (OR), and the length of the black lines shows 95% (CI) confidence intervals.

Publication data DOI Study design Type of therapy Diagnosis Material Investigated follow-up periods 6 months follow-up 12 months follow-up 24 months follow-up Funding sources Conflict of interest Sample size Number of success cases Number of failed cases Sample size Number of success cases Number of failed cases Sample size Number of success cases Number of failed cases
ContinuedVol:.(1234567890) Scientific Reports | (2024) 14:18421 | https://doi.org/10.1038/s41598-024-69367-7www.nature.com/scientificreports/

months follow-up 12 months follow-up 24 months follow-up Funding sources Conflict of interest Sample size Number of success cases Number of failed cases Sample size Number of success cases Number of failed cases Sample size Number of success cases Number of failed cases
ContinuedVol.:(0123456789)Scientific Reports | (2024) 14:18421 | https://doi.org/10.1038/s41598-024-69367-7www.nature.com/scientificreports/

Table 1 .
Baseline characteristics of the included studies.rct: randomized controlled trial.* In this study the 36 months data were used.** In this study 8 months and 16 monts data were used.